Article thumbnail

Adult Patients with Congenital Adrenal Hyperplasia Have Elevated Blood Pressure but Otherwise a Normal Cardiovascular Risk Profile

By Christiaan F. Mooij, Jeanne Margot Kroese, Fred C. G. J. Sweep, Ad R. M. M. Hermus and Cees J. Tack
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3164719
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1997). A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols.
  2. (2003). Adiponectin and protection against type 2 diabetes mellitus.
  3. (2009). Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
  4. (2007). Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
  5. (2000). Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
  6. (2006). Cortisol metabolism in hypertension.
  7. (1999). ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA-PAI-1 and tPA-PAI-1).
  8. (2004). Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels.
  9. (2010). Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients.
  10. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
  11. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.
  12. (2005). Mechanisms of mineralocorticoid action.
  13. (2007). Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
  14. (2009). Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.
  15. (1994). Morbidity and mortality in Cushing’s disease: an epidemiological approach.
  16. (2002). NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
  17. (2009). Pioglitazone improves insulin resistance and decreases blood pressure in adult patients with congenital adrenal hyperplasia.
  18. (2004). Plasma adiponectin levels and risk of myocardial infarction in men.
  19. (2006). Premature mortality in patients with Addison’s disease: a population-based study.
  20. (2005). Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha.
  21. (2011). Thore ´n M
  22. (2010). Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?